These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9516171)

  • 1. Chronic graft-versus-host disease and seizure.
    Azuno Y; Yaga K; Kaneko T; Kaku K; Oka Y
    Blood; 1998 Apr; 91(7):2626-8. PubMed ID: 9516171
    [No Abstract]   [Full Text] [Related]  

  • 2. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
    Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial premature ageing as a side-effect following bone marrow transplantation.
    Selvaag E; Jacobsen N; Thomsen K
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):566-8. PubMed ID: 12941096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.
    Anguenot JL; Ibéchéole V; Helg C; Piacenza JM; Dumps P; Bonnefoi H
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):185-7. PubMed ID: 12069746
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight loss, skin rash, and cough following bone marrow transplantation for chronic myelogenous leukemia.
    Witherspoon RP; McGlave P; Campbell JB; Sigley T; Rolston KV
    Cancer Pract; 1998; 6(4):202-5. PubMed ID: 9767331
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
    Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosing graft versus host disease.
    O'Rourke ME; High K
    Clin J Oncol Nurs; 2000; 4(1):47-8. PubMed ID: 10865586
    [No Abstract]   [Full Text] [Related]  

  • 8. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
    Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
    Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
    [No Abstract]   [Full Text] [Related]  

  • 9. Esophageal graft versus host disease.
    Sodhi SS; Srinivasan R; Thomas RM
    Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
    Niederwieser D; Arcese W; Bandini G; Schwaighofer H; Thaler J; Bosi A; Di Bartolomeo P; Alessandrino EP; Urban C; Gratwohl A
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):40-3. PubMed ID: 8235706
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft-versus-leukemia: no longer an epiphenomenon.
    Antin JH
    Blood; 1993 Oct; 82(8):2273-7. PubMed ID: 8400279
    [No Abstract]   [Full Text] [Related]  

  • 12. Penetrating keratoplasty in severe ocular graft versus host disease.
    Heath JD; Acheson JF; Schulenburg WE
    Br J Ophthalmol; 1993 Aug; 77(8):525-6. PubMed ID: 8025052
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
    Porter DL; Roth MS; McGarigle C; Ferrara JL; Antin JH
    N Engl J Med; 1994 Jan; 330(2):100-6. PubMed ID: 8259165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal rhabdomyolysis as a complication of bone marrow transplantation.
    Volin L; Järventie G; Ruutu T
    Bone Marrow Transplant; 1990 Jul; 6(1):59-60. PubMed ID: 2390634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GVL and GVHD following the infusion of a limited number of donor CD3 cells in the therapy of leukaemia relapse after bone marrow transplantation.
    du Toit C; Novitzky N
    Eur J Haematol; 1999 Jan; 62(1):68-9. PubMed ID: 9918315
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
    Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
    Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
    Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial mucoceles and lichenoid graft versus host disease: report of three cases.
    García-F-Villalta MJ; Pascual-López M; Elices M; Daudén E; García-Diez A; Fraga J
    Acta Derm Venereol; 2002; 82(6):453-5. PubMed ID: 12575854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for marrow transplantation in chronic myelogenous leukemia.
    Thomas ED; Clift RA
    Blood; 1989 Mar; 73(4):861-4. PubMed ID: 2645947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.